Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012
Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005
Transferrin in patients with idiopathic pulmonary arterial hypertension: correlation with exercise capacity Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009
Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013
Resting DLCO predictis exercise lung gas exchange efficiency but not walking distance at 6‘WT in idiopathic pulmonary artery hypertension (IPAH) Source: Eur Respir J 2005; 26: Suppl. 49, 106s Year: 2005
Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Intra-breath CO-diffusion and pulmonary blood flow at rest and during exercise in pulmonary arterial hypertension and pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 403s Year: 2004
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010
Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012
Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007
Comparison of exercise capacity, pulmonary functions, respiratory and peripheral muscle strength between patients with idiopathic pulmonary arterial hypertension and Eisenmenger syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Low DLCO in pulmonary vascular diseases Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021
Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses Source: Eur Respir J 2013; 42: 1575-1585 Year: 2013
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003
Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014
Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005
Contrasting physiological responses to the six minute walk test in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH) Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Pulmonary hypertension in idiopathic pulmonary fibrosis: correlation to pulmonary function and exercise parameters Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007